Ventricular Fibrillation

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

What Is Heart Failure? What Causes Heart Failure?

Published July 9, 2009, 3:17 am, Medical News Today

Even though it may sound like it, heart failure does not necessarily mean that the heart has failed. Heart failure is a serious condition in which the heart is not pumping blood around the body efficiently. The patient's left side, right side, or even both sides of the body can be affected. Symptoms will depend on which side is affected and how severe the heart failure is - symptoms can be severe.

Discover News | Full Story


Multaq approved for atrial fibrillation by FDA

Published July 7, 2009, 7:18 pm, News-Medical-Net

Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. Multaq is the first drug approved in the United States that has shown a clinical benefit to reduce cardiovascular ...

Discover News | Full Story


Between 1992 And 2005 Survival Rates For Elderly Receiving Hospital CPR Did Not Improve

Published July 7, 2009, 3:17 am, Medical News Today

A study of elderly patients receiving CPR in the hospital shows that rates of survival did not improve from 1992 to 2005. During that period, the proportion of hospital deaths preceded by CPR rose, and the proportion of patients who were successfully resuscitated and later discharged home fell. The researchers found that 18.

Discover News | Full Story


FDA Approves Multaq For Patients With Atrial Fibrillation Or Atrial Flutter

Published July 7, 2009, 1:24 am, PharmaceuticalOnline

Sanofi-aventis announced recently that the U.S. Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg Tablets.

Discover News | Full Story


Sorin Group Announces Regulatory Approval And First Implants Of New-Platform FACIL And REPLY Pacemakers In Japan

Published July 6, 2009, 6:36 am, Medical News Today

Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced the Ministry of Health, Labor and Welfare (MHLW) approval to market the FACIL™ and REPLY™ families of dual and single chamber rate responsive pacemakers.

Discover News | Full Story


Survival rates for elderly receiving hospital CPR did not improve from 1992 to 2005

Published July 6, 2009, 6:29 am, EurekAlert!

( University of Washington ) A study of elderly patients receiving CPR in hospitals shows that rates of survival did not improve from 1992 to 2005. The proportion of hospital deaths after CPR rose, and the proportion of patients who were successfully resuscitated and later discharged home fell. Black patients were more likely to receive CPR, but less likely to survive. Older people, men, and ...

Discover News | Full Story


HEALTH: Hearts of the elderly

Published July 5, 2009, 3:01 pm, The Malay Mail

Nenek passed away Friday. She had survived two heart attacks but the third, all in a space of three months, proved too much for her. She was 93 years old.

Discover News | Full Story


Implantable Defibrillators Can Be Beneficial at Any Age

Published July 4, 2009, 8:54 am, ThirdAge

Heart patients over the age of 70 have often been excluded from clinical trials, sometimes based only on their age, but a U.S. study released last week has established that patients over the age of 70 can benefit from some of the same treatments as younger patients.

Discover News | Full Story


FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter

Published July 3, 2009, 5:07 am, Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease.

Discover News | Full Story


*vwd/BUSINESS WIRE: Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY ...

Published July 2, 2009, 10:48 pm, vwd.de

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a